Phantom Evolution
3%/3mm criteria showing 99.2% passing rate, a good test of deliverability and machine performance.
3DVH uses ArcCHECK QA measurements to estimate 3D dose to the patient geometry.
3%/3mm criteria showing 99.2% passing rate, a good test of deliverability and machine performance.
Evaluating the same plan, 3DVH shows substantial target underdose, indicating that although the plan was properly delivered, the clinicial impact was below expectations.